all countries, coronavirus, COVID-19, patient advocacy, UK
Pseudomyxoma Survivor is immensely proud to be a member of Cancer52. Cancer52 represents predominantly small patient support group cancer charities such as ourselves and by coming together, we aim to promote improved diagnosis, treatment and support for those affected...
all countries, patient advocacy, The Christie
All ready for tomorrow’s trip to The Christie. A little something for each of the staff that help to look after Pseudomyxoma...
all countries, patient advocacy, Treatment
The current climate has presented us with many issues and one of the greatest concerns is not many of us have visited a hospital for care during the COVID-19 pandemic. Given the significant disruption that COVID-19 caused to cancer diagnosis and treatment, combined...
all countries, patient advocacy, research, Volunteering
In December, Susan and Angela have been asked to present at the EuroPMP International Workshop on pseudomyxoma peritonei. It is a privilege to be asked to present to this network of experts from many fields, including surgeons, pathologists, oncologists, radiologists,...
all countries, country, patient advocacy, Treatment, UK
One of the connections we have made this year is with National Voices, the coalition of charities that stands for people being in control of their health and care. National Voice has drawn our attention to a new report published by Cancer Research UK, ‘Securing a...
all countries, patient advocacy, raising awareness, Trustees
One of the recommendations of the Charity Commission, whoregister and regulate charities in England and Wales, is that charities work with other charities. This is extremely important to the trustees of Pseudomyxoma Survivor and key to a lot of the things we do. We...
all countries, patient advocacy
I am finally getting round to informing you all of my recent visit to West Yorkshire & Harrogate Cancer Alliance. We were invited by Cancer 52 and the meeting was a great and informative one, attended by other Cancer 52 charities such as Target Ovarian Cancer,...
all countries, country, diagnosis, patient advocacy
Through Cancer 52, Pseudomyxoma Survivor has received a special invitation to view a multi-disciplinary diagnostic centre (MDC) in action. MDCs are being trialled here in the UK and they are set up so that patients who present with non-specific symptoms can go to a...
all countries, patient advocacy, PSOGI, raising awareness
Pseudomyxoma Survivor representatives once again attended the bi-annual Peritoneal Surface Oncology Group International (PSOGI) conference, this time it was in Paris. The PSOGI aims to “improve the treatment and survival of peritoneal cancer patients by educating...
Recent Comments